Reflections on a Year of SARS-CoV-2.
作者信息
Abeles Elisabeth, Azamfirei Razvan
机构信息
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
J Crit Care Med (Targu Mures). 2021 Jan 29;7(1):3-5. doi: 10.2478/jccm-2021-0005. eCollection 2021 Jan.
Abstract
摘要
相似文献
1
Reflections on a Year of SARS-CoV-2.对新冠病毒流行一年的反思
J Crit Care Med (Targu Mures). 2021 Jan 29;7(1):3-5. doi: 10.2478/jccm-2021-0005. eCollection 2021 Jan.
2
Are urologists in trouble with SARS-CoV-2? Reflections and recommendations for specific interventions.泌尿科医生是否受到 SARS-CoV-2 的困扰？具体干预措施的反思和建议。
BJU Int. 2020 Dec;126(6):670-678. doi: 10.1111/bju.15141. Epub 2020 Aug 17.
3
Reflections on 2020, the year of COVID.
R I Med J (2013). 2020 Dec 1;103(10):7-11.
4
ASO Author Reflections: Oncological Surgery during the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection.《血管外科学会作者反思：2019年冠状病毒病大流行期间的肿瘤外科手术：术前筛查的有效性及与术后严重急性呼吸综合征冠状病毒2感染相关的因素》
Ann Surg Oncol. 2022 Apr;29(4):2163-2164. doi: 10.1245/s10434-021-11201-9. Epub 2022 Jan 7.
5
The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.SARS-CoV-2 的突变特征主要由宿主抗病毒防御决定。
Viruses. 2021 Mar 2;13(3):394. doi: 10.3390/v13030394.
6
[Reflections on the quality of health care after the SARS-CoV-2 pandemic].[关于2019冠状病毒病大流行后医疗保健质量的思考]
J Healthc Qual Res. 2020 Mar-Apr;35(2):61-63. doi: 10.1016/j.jhqr.2020.03.004.
7
The ugly, the bad and the good: Reflections on a COVID-19-devastated year.丑恶、糟糕与美好：对新冠疫情肆虐之年的反思
Waste Manag Res. 2021 Jun;39(1_suppl):1-2. doi: 10.1177/0734242X211024386. Epub 2021 Jun 2.
8
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与输血医学：来自意大利的思考
Blood Transfus. 2020 Mar;18(2):77-78. doi: 10.2450/2020.0071-20.
9
Scientific evidence on the origin of SARS-CoV-2.关于 SARS-CoV-2 起源的科学证据。
Environ Res. 2023 Jan 1;216(Pt 2):114631. doi: 10.1016/j.envres.2022.114631. Epub 2022 Oct 19.
10
[Reflections on the Global Pandemic of COVID-19 and the Response Strategies].[关于新冠疫情全球大流行及应对策略的思考]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Nov;52(6):936-938. doi: 10.12182/20211160103.
本文引用的文献
1
COVID -19 Complicated By Acute Respiratory Distress Syndrome, Myocarditis, and Pulmonary Embolism. a Case Report.新型冠状病毒肺炎合并急性呼吸窘迫综合征、心肌炎和肺栓塞：一例病例报告
J Crit Care Med (Targu Mures). 2021 May 12;7(2):123-129. doi: 10.2478/jccm-2020-0041. eCollection 2021 Apr.
2
Multisystem inflammatory syndrome in children.儿童多系统炎症综合征。
Curr Opin Pediatr. 2021 Feb 1;33(1):152-158. doi: 10.1097/MOP.0000000000000974.
3
Anticoagulation in COVID - 19: An Update.2019冠状病毒病的抗凝治疗：最新进展
J Crit Care Med (Targu Mures). 2020 Nov 7;6(4):217-223. doi: 10.2478/jccm-2020-0033. eCollection 2020 Oct.
4
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.2020 年 3 月至 8 月，英国和美国出现与 SARS-CoV-2 感染相关的成人多系统炎症综合征病例系列。
MMWR Morb Mortal Wkly Rep. 2020 Oct 9;69(40):1450-1456. doi: 10.15585/mmwr.mm6940e1.
5
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力：一项实时系统评价和荟萃分析。
PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.
6
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响：CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
7
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.COVID-19 引起的 ARDS 的临床特征、通气管理和预后与其他原因引起的 ARDS 相似。
Intensive Care Med. 2020 Dec;46(12):2200-2211. doi: 10.1007/s00134-020-06192-2. Epub 2020 Jul 29.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
9
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.比较 SARS-CoV-2 与 SARS-CoV 和流感大流行。
Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3.
10
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
Zotero 插件